NCT05763043View on ClinicalTrials.gov

Monoferric for Prenatal Iron Deficiency

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Obstetric Labor Complications
Interventions
DRUG

Ferric derisomaltose

Participants between the gestational ages of 14 to 42 weeks with iron deficiency will receive IV Ferric derisomaltose at a routine prenatal visit.

Trial Locations (1)

97239

RECRUITING

Oregon Health & Science Univerity, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER